Medical/Pharmaceuticals
FlexEnable Acquires Merck's OTFT Materials Portfolio for Flexible Displays
CAMBRIDGE, England, Nov. 7, 2019 /PRNewswire/ -- FlexEnable, the leader in the development and industrialisation of flexible organic electronics, has acquired Merck's portfolio of best-in-class, high-performance Organic Thin-Film Transistor (OTFT) materials, including revolutionary and highly-pat...
2019-11-07 12:00
1649
ASH 2019 | CStone's anti-PD-L1 antibody demonstrates a complete response rate of 31.8% in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma
SUZHOU, China, Nov. 7, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that an abstract on the CS1001-201 trial (Abstract #2833) was accepted by the 2019 American Society of Hematology (ASH) Annual Meeting and has been published online yesterday...
2019-11-07 11:02
2504
First Asia-Pacific hospital treats patients with RayStation and Radixact
SUNNYVALE, California, Nov. 7, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) –Thailand's Lopburi Cancer Hospital, a center of excellence for cancer treatment, is the first in theAsia-Pacific region to clinically use the combination of RaySearch's treatment planning system RayStation® w...
2019-11-07 09:00
2738
AiCure Raises $24.5 Million Series C Round to Broaden Its Strategic Value for Life Sciences
NEW YORK, Nov. 7, 2019 /PRNewswire/ -- AiCure, recognized as one of the world's 100 most innovative artificial intelligence companies, announced a Series C fundraising round totaling$24.5 million. The financing was led by Palisades Growth Capital (PGC) with new investors from Singtel Innov8 (Inno...
2019-11-07 08:01
2048
Bioeq Announces Coherus as Marketing and Distribution Partner for Its Biosimilar to Lucentis® (ranibizumab) in the U.S.
- Bioeq agreement brings promise of their leading Lucentis® biosimilar for the treatment of retinopathies one step nearer for U.S. patients - ZÜRICH, Nov. 7, 2019 /PRNewswire/ -- Bioeq IP AG ("Bioeq") today announced that it signed a license and development agreement with Coherus BioSciences, In...
2019-11-07 05:14
2254
Antengene Corporation Announces Exclusive Worldwide License to Develop and Commercialize AZD0364
SHANGHAI and LONDON, Nov. 7, 2019 /PRNewswire/ -- Antengene Corporation today announced that it has entered into a licensing agreement with AstraZeneca (LSE/STO/NYSE: AZN) under which Antengene has been granted the exclusive global rights to further develop and commercialize AZD0364. Antengene Co...
2019-11-07 01:40
2563
Henlius HLX01 (Rituximab Injection) Wins "Biosimilar Initiative of the Year" at Global Generics & Biosimilars Awards 2019
SHANGHAI, Nov. 7, 2019 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK), a leading biopharmaceutical company inChina focusing on oncology and autoimmune diseases, won the award of "Biosimilar Initiative of the Year" (HLX01, rituximab injection) and was also shortlisted for the award of "t...
2019-11-07 01:00
2604
Polynoma Presenting Interim Phase III Data for Its Investigational Melanoma Vaccine, Seviprotimut-L, at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting
-- MAVIS Study Identifies Most Responsive Patient Subpopulations, Supporting the Continued Study of Adjuvant Treatment in Localized Melanoma Patients -- SAN DIEGO, Nov. 6, 2019 /PRNewswire/ -- Polynoma LLC, a U.S. immuno-oncology focused biopharmaceutical company and wholly-owned subsidiary ofHon...
2019-11-06 20:00
7232
EpiVax Announces Publication of Antigen-Specific Tolerance Induction by Tregitope in Nature Scientific Reports
PROVIDENCE, Rhode Island, Nov. 6, 2019 /PRNewswire/ -- EpiVax, Inc. ("EpiVax"), a pioneer in immunoinformatics innovation, announces the publication of "Therapeutic administration of Tregitope-Human Albumin Fusion with Insulin Peptides to promote Antigen-Specific Adaptive Tolerance Induction" inS...
2019-11-06 18:01
1692
Nanoform Wins the CPhI Excellence in Pharma Award for Formulation
HELSINKI, Nov. 6, 2019 /PRNewswire/ -- Nanoform, an innovative medicine enabling nanotechnology company, has won the Excellence in Pharma Award for Formulation at the prestigious CPhI Pharma Awards. Receiving this highly contested prize is an acknowledgement of Nanoform's commitment to innovation...
2019-11-06 17:21
1259
WuXi AppTec Receives Investment Grade Corporate Ratings from Three Global Rating Agencies
SHANGHAI, Nov. 6, 2019 /PRNewswire/ -- WuXi AppTec announced today that it has received investment grade corporate credit ratings from three global rating agencies: Moody's (Baa3), S&P Global Ratings (BBB-), and Fitch Ratings (BBB-); all three agencies maintain a stable outlook on WuXi AppTec. Th...
2019-11-06 16:00
1288
Olympus Unveils Corporate Strategy
* Medical business to drive future growth of Olympus Corporation as a global medtech leader * A thorough transformation plan implemented to drive the change from within and ensure goals are achieved * As a result >20% operating profit margin is targeted at the fiscal year March 2023 TOKYO, ...
2019-11-06 14:08
966
15 Years of P-MEC China Driving Global Pharma Technology Forward in China
SHANGHAI, Nov. 6, 2019 /PRNewswire/ -- P-MEC China
2019-11-06 14:00
605
Wiley Partners With Editage to Enhance and Expand Services for Authors
LONDON, Nov. 6, 2019 /PRNewswire/ -- John Wiley & Sons Inc. is pleased to announce a new partnership with Editage, a leading global scholarly communications brand by Cactus Communications (CACTUS), to enhance and expand the services available from Wiley Editing Services. This partnership enables ...
2019-11-06 11:00
3305
Hebron Technology Co., Ltd. to Hold Annual Meeting of Shareholders on December 20, 2019
WENZHOU, China, Nov. 5, 2019 /PRNewswire/ -- Hebron Technology Co., Ltd. (" Hebron" or the "Company") (Nasdaq: HEBT), a developer, manufacturer and installer of valves and pipe fittings for use in the pharmaceutical, biological, food and beverage, and other clean industries, today announced that ...
2019-11-06 05:05
8188
Inovio Demonstrates 80% 6-Month Progression-Free Survival In Phase 2 Glioblastoma Multiforme (GBM) Study with INO-5401 In Combination with PD-1 Inhibitor Libtayo® (cemiplimab)
80% of Methylated Patients and 75% of Unmethylated Patients Were Disease Progression-Free at 6 Months PLYMOUTH MEETING, Pennsylvania, Nov. 5, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today positive interim results from Inovio's Phase 2 study (NCT03491683) of newl...
2019-11-05 21:00
2606
Cognate BioServices announces acquisition of Cobra Biologics
- Transformative acquisition creates global cell and gene therapy manufacturing services platform for both clinical and commercial products - EW Healthcare Partners and its co-investors provide the financing for the transaction MEMPHIS, Tennessee, Nov. 5, 2019 /PRNewswire/ -- Cognate BioServices...
2019-11-05 12:32
2413
Farrer Park Hospital Introduces High Intensity Focused Ultrasound (HIFU) Treatment for Uterine Fibroid in Singapore
SINGAPORE, Nov. 5, 2019 /PRNewswire/ -- Farrer Park Hosiptal (FPH) introduces High Intensity Focused Ultrasound (HIFU) inSingapore. HIFU is a new technology for the treatment of uterine fibroids, adenomyoma, adenomyosis. It is a non-invasive surgery that uses focused ultrasound to generate hig...
2019-11-05 09:00
4035
Samsung Biologics and Ichnos Sciences Announce Agreement for Manufacture of ISB 830
INCHEON, South Korea, Nov. 4, 2019 /PRNewswire/ -- Samsung Biologics announced the signing of a long-term agreement with Ichnos Sciences for manufacturing drug substance for ISB 830, an anti-OX40 monoclonal antibody in development as a potential treatment for moderate-to-severe atopic dermatitis....
2019-11-05 08:22
1148
Health Charities Benefit from Nationwide Fundraising Campaign
SYDNEY, Nov. 5, 2019 /PRNewswire/ -- AFT Pharmaceuticals is getting behind three charities in a bid to help them raise vital funding for vulnerable Aussies - and get people talking about health. The company's founder and CEO, Hartley Atkinson says the initiative is an opportunity to give back to...
2019-11-05 05:30
989
Week's Top Stories
Most Reposted
Alpha Trading Cup 2024 Award Night: Top Trader Achieves Remarkable 315% Profit, as Over 1,149 Competitors Vie for USD 44,000 Prize Pool
[Picked up by 313 media titles]
2024-10-25 18:29
International Golo Mori Jazz 2024: Experience the Harmony of Eastern Indonesia's Exotic Beauty and Romantic Jazz Music
[Picked up by 300 media titles]
2024-10-25 22:48
2024 Malaysia E-commerce Product Selection Expo Reaches Major Milestone Attracting Leading Brands and Businesses From China
[Picked up by 300 media titles]
2024-10-25 07:00
RuggON Showcases Latest Mining Technology at IMARC 2024
[Picked up by 297 media titles]
2024-10-28 14:32
TotalEnergies ENEOS Completes a 1.8 MWp Floating Solar Photovoltaic System Project, a Second Collaboration with S. Kijchai Enterprise in Thailand
[Picked up by 288 media titles]
2024-10-29 11:24
Most Read
Alpha Trading Cup 2024 Award Night: Top Trader Achieves Remarkable 315% Profit, as Over 1,149 Competitors Vie for USD 44,000 Prize Pool
2024-10-25 18:29
8610
International Golo Mori Jazz 2024: Experience the Harmony of Eastern Indonesia's Exotic Beauty and Romantic Jazz Music
2024-10-25 22:48
7462
Infobip and Singtel Partner to Advance Customer Engagement for Singapore Businesses with Rich Communication Services
2024-10-25 12:30
7039
Global development relies on cooperation
2024-10-25 12:38
6056
Peak Energy CEO Gavin Adda Speaks at Asia Clean Energy Summit 2024
2024-10-25 18:30
5759
